1. New antitumor drug with significant clinical activity;Blum;Ann. Int. Med.,1974
2. The clinical evaluation of analogs-III. anthracyclines;Carter;Cancer Chemother. Pharmacol.,1980
3. New antitumor antibiotics, aclacinomycins A and B;Umezawa;J. Antibiotics,1975
4. Antitumor spectrum of a new anthracycline, (2″R)-4′-O-tetrahydropyranyl-adriamycin, and effect on the cellular immune response in mice;Hisamatsu;Jpn. J. Cancer Res.,1985
5. A phase I study of 4′-epi-adriamycin, a new anthracycline anticancer agent;Kimura;Jpn. J. Cancer Chemother.,1984